perioperative management of glp-1 agonists Anesthetic Considerations for Patients Taking Glucagon-Like Peptide-1 Perioperative anesthesia management of GLP-1
Description
Cignas announcement to phase out rebates in favor of upfront discounts is an important signal that the system needs change
Importantly, this decision applied only to the obesity indication ( 7 , 8 )
GIP reduces apoptosis in mouse pancreatic -cells by enhancing the expression of the antiapoptotic gene B-cell/CLL lymphoma 2 (Bcl-2) through the PKA-mediated formation of a phosphorylated cAMP response element-binding protein (CREB) and target of rapamycin complex 2 (TORC2) complex
OPTIMAL DX MEMBERS CLICK HERE to learn more about GLP-1, phytochemicals, health benefits, etc.
It's not insulin-rather, it mimics the effects of the glucagon-like peptide-1 (GLP-1) hormone, which helps manage blood glucose levels post-meal
